ENT UPDATE 2015, on Sunday, 6th December.MAMC ,Delhi

BROCHURE


The Department of ENT - Head and Neck Surgery, Maulana Azad Medical College invites all ENT surgeons for the ENT UPDATE 2015, on Sunday, 6th December.
The theme for the update shall be "Challenges faced by young ENT surgeons".
Although there is no registration fee, prior registration for the update is mandatory.
For further details contact the following via whatsapp/sms/email:
Dr. Ramanuj Bansal 9968392768
Dr. Ravi Meher 9968604237
Dr. Vikas Malhotra 9968604238
Email: mamcentall@gmail.com

26th Congress of the European Rhinologic Society / 35th International Symposium of Infection and Allergy of the Nose / 17th International Rhinology Society,3-7 July, 2016 in Stockholm, Sweden




ERS 2016: Save the Date26th Congress of the European Rhinologic Society / 35th International Symposium of Infection and Allergy of the Nose / 17th International Rhinology Society
3-7 July, 2016 in Stockholm, Sweden
In 2016, ERS goes “nobel” in Stockholm! Join us and make your essential contribution to our think-tank with the theme “Rhinological disorders – a health priority for the future”. ERS 2016 is a unique opportunity to interact on a scientific level with international colleagues, as well as partake in an unforgettable social event.
To learn more, visit www.ers-isian2016.com
Prof. dr. Pär Stjärne
President of ERS 2016 Congress

“SNORING AND SLEEP APNOEA” to be held on 17th and 18th October 2015 at Aurangabad,




Dear colleagues, 

We are happy to invite you for the LIVE SURGICAL WORKSHOP ON  “SNORING AND SLEEP APNOEA” to be held on 17th   and  18th  October  2015 at Aurangabad, (Maharashtra), India. The event is in association with Indian Association of Surgeons for Sleep Apnoea. The delegates will get Four accreditation points by Maharashtra Mediacal Council.
Venue – ADVANCED ENT & MULTISPECIALITY HOSPITAL PVT. LTD;
            Near Gajanan Mandir, Pundalik Nagar Road, Beside Essar Petrol Pump,
            Aurangabad, (Maharashtra) - 431001

Faculty - Dr SEEMAB SHAIKH (PUNE)
                Dr VIKAS AGRAWAL (MUMBAI)
                Dr SHRINIWAS KISHORE ( HYDERABAD)


Phone: +91 9822127400, +91 9922504394

Registration fee – Consultant- Rs 3000 ( upto 20th  Sept)
                          PG Student : Rs.1500 ( upto 20th  Sept)

Demand draft should be in favour of “ADVANCED ENT & MULTISPECIALITY HOSPITAL PVT. LTD” payable at Aurangabad.

Thanking You,
Sincerely,
Dr Sachin nagre
Director,
ADVANCED ENT & MULTISPECIALITY HOSPITAL PVT. LTD;
Aurangabad, (Maharashtra), India.


Age and the prognosis of tympanoplasty type I.

Age and the prognosis of tympanoplasty type I.

Abstract

The purpose of this study is to evaluate the influence of the age factor on the prognosis for tympanoplasty type I. One hundred subjects (41 males, 59 females, 16-65 years old, mean age 37.9 years old) who accepted tympanoplasty type I during a four-year period were reviewed. The success rate of the surgery was analyzed using the three criteria suggested by the Japan Clinical Otology Committee. In addition, linear regression was used to analyze the correlations between age and pre-operative hearing, post-operative hearing and hearing gain. Using the proportion of patients with a postoperative hearing threshold within 40 dB as the criterion, the 16-25 year-old group had the best results (80%) and the 56-65 year-old group had the worst results (66.7%). Using hearing gain exceeding 15 dB as the criterion, the best result was for the 36-45 year-old group (60.9%), and the worst result was for the 56-65 year-old group (26.7%). Using post-operative air-bone gap within 20 dB as the criterion, the best result was for the 16-25 year-old group (70%), and the worst result was for the 56-65 year-old group (40%). The best total success rate was for the 16-25 year-old group (80%) and the worst was for the 56-65 year-old group (66.7%). The total average success rate was 74%. Linear regression analysis showed that the postoperative hearing thresholds increased significantly with advancing age. But there was no statistically significant difference in hearing gain between the various age groups and the preoperative hearing thresholds also increased with advancing age. In conclusion, although tympanoplasty type I offered the patients a similar hearing gain among the different age groups, from the point of view of social function, it offered younger people a better chance of social hearing than the elderly and a higher surgical success rate. The poor postoperative hearing of the elderly was a result of their poor preoperative hearing condition.
PMID:
 
9796197
 
[PubMed - indexed for MEDLINE]

Correlation between the characteristics of resonance and aging of the external ear.

Correlation between the characteristics of resonance and aging of the external ear.

[Article in English, Portuguese]

Abstract

PURPOSE:

Aging causes changes in the external ear as a collapse of the external auditory canal and tympanic membrane senile. Knowing them is appropriate for the diagnosis of hearing loss and selection of hearing aids. For this reason, the study aimed to verify the influence of the anatomical changes of the external ear resonance in the auditory canal in the elderly.

METHODS:

The sample consisted of objective measures of the external ear of elderly with collapse (group A), senile tympanic membrane (group B) and without changing the external auditory canal or tympanic membrane (group C) and adults without changing the external ear (group D). In the retrospective/clinical study were performed comparisons of measures of individuals with and without alteration of the external ear through the gain and response external ear resonant frequency and the primary peak to the right ear.

RESULTS:

In groups A, B and C was no statistically significant difference between Real Ear Unaided Response (REUR) and Real Ear Unaided Gain (REUG), but not for the peak frequency. For groups A and B were shown significant differences in REUR and REUG. Between the C and D groups were significant statistics to the REUR and REUG, but not for the frequency of the primary peak.

CONCLUSION:

Changes influence the external ear resonance, decreasing its amplitude. However, the frequency of the primary peak is not affected.
PMID:
 
24918503
 
[PubMed - indexed for MEDLINE] 
Free full text

Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.

 2014 Jan;38(1):68-79. doi: 10.1007/s00268-013-2224-1.

Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.

Abstract

BACKGROUND:

Total thyroidectomy is well accepted as initial surgery for papillary thyroid cancer (PTC), but the extent of the thyroidectomy remains a matter of controversy. This study was designed to investigate the long-term clinical outcome of PTC patients who had undergone thyroid lobectomy and to elucidate the indications of lobectomy as initial surgery.

METHODS:

The cases of 1,088 PTC patients who underwent thyroid lobectomy with curative intent at Ito Hospital between 1986 and 1995 were analyzed retrospectively in this study. None of the patients had received postoperative radioactive iodine (RAI) ablation therapy. The median follow-up period was 17.6 years. All clinical outcomes, including recurrence and death as a result of PTC or other reasons, were evaluated. To establish the indications for lobectomy as initial surgery for PTC, the potential risk factors, such as age, sex, primary tumor size, extrathyroidal invasion, and clinical lymph node metastasis at the time of the initial surgery, were assessed statistically for associations with recurrence and disease-related death.

RESULTS:

The remnant-thyroid recurrence-free survival (RT-RFS) rate, the regional- lymph-node recurrence-free survival (L-RFS) rate, and the distant-recurrence-free survival (D-RFS) rate as of 25 years after surgery were 93.5, 90.6, and 93.6%, respectively. The cause-specific survival (CSS) rate at 25 years was 95.2%. Univariate and multivariate analyses showed that none of the factors assessed were significantly associated with the RT-RFS rate. Tumor size, clinical lymph node metastasis, and extrathyroidal invasion were significantly associated with the L-RFS rate. The D-RFS and CSS rates were both significantly lower in the group of patients who were aged 45 years old or older, the group whose tumors were larger than 40 mm, and the group with extrathyroidal invasion. Based on the above findings, we classified the patients into four groups according to age <45 or ≥ 45 years, tumor size ≤ 40 or >40 mm, whether clinical lymph node metastasis was present, and whether extrathyroidal invasion was present. None of the patients without any of these four risk factors died of PTC. On the other hand, 22 patients who died of PTC were positive for one or more of these four factors.

CONCLUSIONS:

The long-term clinical outcome of the PTC patients who had been treated by lobectomy without RAI ablation was excellent. Based on the above results, we concluded that lobectomy is a valid alternative to total thyroidectomy for the treatment of PTC patients who are younger than aged 45 years, whose tumor diameter is 40 mm or less, and who do not have clinical lymph node metastasis or extrathyroidal invasion.
PMID:
 
24081532
 
[PubMed - indexed for MEDLINE]

Tata Memorial in association with Lumenis announces 2nd CO2 laser Course in Head & Neck Oncology City: Mumbai Venue: Tata Memorial Hospital, Mumbai


Brief: Tata Memorial Hospital in association with Lumenis hosting 2nd Co2 laser course at Tata Memorial Hospital, Mumbai

Conference Name: 2nd CO2 laser Course in Head & Neck Oncology
Heading: Tata Memorial in association with Lumenis announces 2nd CO2 laser Course in Head & Neck Oncology
City: Mumbai
Venue: Tata Memorial Hospital, Mumbai
Dates: 24-25th October
Organizing Team: Dr Anil D’Cruz, Dr Devender Chaukar, Dr Prathamesh Pai, (Tata Team)
International Faculty: Dr Giorgio Peretti
National Faculty: Dr. Devendra Chaukar, Dr. Pankaj Chaturvedi, Dr. Prathamesh Pai, Dr. Gouri Pantvaidya, Dr. Anuja Deshmukh, Dr. Deepa Nair, Dr. Sudhir Nair
Fees detail: Rs 2500 for consultant, 1000 for PG

Brochure is attached


Aviral Shrivastava
Product Manager – ENT, Surgical

Lumenis India Pvt Ltd
office +91 124 48549 08 mobile +91981 11280 32 fax +91 124 425 49 32